Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Cervical Cancer, December 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 331 articles:
HTML format


 

Single Articles

  1. DU H, Qu X, Wang G, Guo C, et al
    Application an internet facilitation in a community-based cervical cancer screening project.
    BMC Womens Health. 2023;23:641.
    PubMed    
    Abstract available

  2. MONK BJ, Toita T, Wu X, Vazquez Limon JC, et al
    Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial.
    Lancet Oncol. 2023;24:1334-1348.
    PubMed    
    Abstract available

  3. MILESHKIN LR
    The challenge of improving outcomes in locally advanced cervical cancer.
    Lancet Oncol. 2023;24:1289-1291.
    PubMed    


  4. NIU Z, Yan B
    Prognostic and clinicopathological effect of the prognostic nutritional index (PNI) in patients with cervical cancer: a meta-analysis.
    Ann Med. 2023;55:2288705.
    PubMed    
    Abstract available

  5. YANG S, Ding Y, Li H, Wu S, et al
    Impact of peritoneal vaginoplasty combined with radical hysterectomy on the quality of sexual life for patients with early-stage cervical cancer: trial protocol for a multi-center superiority randomized controlled trial.
    J Gynecol Oncol. 2023 Nov 27. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  6. AFSAH YR, Kaneko N
    Barriers to cervical cancer screening faced by immigrant Muslim women: a systematic scoping review.
    BMC Public Health. 2023;23:2375.
    PubMed    
    Abstract available

  7. CASTANEDA KM, Sidorenkov G, Mourits MJE, van der Vegt B, et al
    Impact of health-related behavioral factors on participation in a cervical cancer screening program: the lifelines population-based cohort.
    BMC Public Health. 2023;23:2376.
    PubMed    
    Abstract available

  8. HABILA MA, Obeng-Kusi M, Ali MJ, Magaji FA, et al
    The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria.
    BMC Womens Health. 2023;23:640.
    PubMed    
    Abstract available

  9. KUNNUMMAL M, Raveendran PS, Basu B, Rani SV, et al
    HPV16 E6/E7-mediated regulation of PiwiL1 expression induces tumorigenesis in cervical cancer cells.
    Cell Oncol (Dordr). 2023 Dec 1. doi: 10.1007/s13402-023-00904.
    PubMed    
    Abstract available

  10. CHIOU PZ
    HPV Primary and Co-testing: An Ethical Analysis Exploring the Role of Cytology in Cervical Cancer Screening and Management.
    J Allied Health. 2023;52:301-304.
    PubMed    
    Abstract available

  11. DZOBO M, Dzinamarira T, Murewanhema G, Chishapira T, et al
    Co-creation of human papillomavirus self-sampling delivery strategies for cervical cancer screening in rural Zimbabwe: nominal group technique.
    Front Public Health. 2023;11:1275311.
    PubMed    
    Abstract available

  12. BEGLIARZADE S, Sufianov A, Ilyasova T, Shumadalova A, et al
    Circular RNA in cervical cancer: Fundamental mechanism and clinical potential.
    Noncoding RNA Res. 2023;9:116-124.
    PubMed    
    Abstract available

  13. LYU Y, Chen X, Liu H, Xi Y, et al
    Comparison of the diagnostic value of [(68) Ga]Ga-FAPI-04 PET/MR and [(18)F]FDG PET/CT in patients with T stage
    Eur J Nucl Med Mol Imaging. 2023 Nov 30. doi: 10.1007/s00259-023-06539.
    PubMed    
    Abstract available

  14. SHVYGIN A, Manning-Geist BL, Sonoda Y
    Fertility-sparing and minimally invasive surgery for early-stage cervical cancer.
    J Surg Oncol. 2023 Nov 30. doi: 10.1002/jso.27540.
    PubMed    


  15. WEI X, Huang Q, Huang J, Yu L, et al
    Erastin induces ferroptosis in cervical cancer cells via Nrf2/HO-1 signaling pathway.
    Int J Immunopathol Pharmacol. 2023;37:3946320231219348.
    PubMed    
    Abstract available

  16. JUNG YK, Park SB, Park HJ, Lee ES, et al
    Recurred Uterine Cervical Cancer Initially Manifesting as Hemorrhagic Cyst: A Case Report Recurred Uterine Cervical Cancer Initially Manifesting.
    Curr Med Imaging. 2023 Nov 29. doi: 10.2174/0115734056271308231120052123.
    PubMed    
    Abstract available

  17. VAN DER SLUIS TC, van Haften FJ, van Duikeren S, Pardieck IN, et al
    Delayed vaccine-induced CD8(+) T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication.
    J Immunother Cancer. 2023;11:e007158.
    PubMed    
    Abstract available

  18. LYCKE KD, Kahlert J, Petersen LK, Damgaard RK, et al
    Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: population based cohort study.
    BMJ. 2023;383:e075925.
    PubMed    
    Abstract available

  19. POSSATI-RESENDE JC, Fritsch TZ, Souza KCB
    Risk Profile of High-grade Cervical Lesions and Cervical Cancer Considering the Combination of Cytology, HPV Genotype, and Age among Women Undergoing Colposcopy.
    Rev Bras Ginecol Obstet. 2023;45:e689-e698.
    PubMed    
    Abstract available

  20. XU T, Jiang J, Xiang X, Jahanshahi H, et al
    Conduction and validation of a novel prognostic signature in cervical cancer based on the necroptosis characteristic genes via integrating of multiomics data.
    Comput Biol Med. 2023;168:107656.
    PubMed    
    Abstract available

  21. ZHAO YC, Wang TJ, Cui J, She LZ, et al
    The role of SLC39A4 in the prognosis, immune microenvironment, and contribution to malignant behavior in vivo and in vitro of cervical cancer.
    Transl Oncol. 2023;40:101839.
    PubMed    
    Abstract available

  22. KROMIDAS E, Geier A, Weghofer A, Liu HY, et al
    Immunocompetent PDMS-free Organ-on-Chip Model of Cervical Cancer Integrating Patient-Specific Cervical Fibroblasts and Neutrophils.
    Adv Healthc Mater. 2023 Nov 29:e2302714. doi: 10.1002/adhm.202302714.
    PubMed    
    Abstract available

  23. LI S, Li X, Zhang S, Feng Y, et al
    Corrigendum: Association between GSDMB gene polymorphism and cervical cancer in the Northeast Chinese Han population.
    Front Genet. 2023;14:1298000.
    PubMed    
    Abstract available

  24. WU Z, Lin Q, Sheng L, Chen W, et al
    A novel immune-related risk-scoring system associated with the prognosis and response of cervical cancer patients treated with radiation therapy.
    Front Mol Biosci. 2023;10:1297774.
    PubMed    
    Abstract available

  25. TIAN P, Deng J, Ma C, Miershali A, et al
    CBX7 is involved in the progression of cervical cancer through the ITGbeta3/TGFbeta1/AKT pathway.
    Oncol Lett. 2023;27:14.
    PubMed    
    Abstract available

  26. GUO D, Huang Y, Wang K, Yang C, et al
    Preparation and Characterization Evaluation of Poly(L-Glutamic Acid)-g-Methoxy Poly(Ethylene Glycol)/Combretastatin A4/BLZ945 Nanoparticles for Cervical Cancer Therapy.
    Int J Nanomedicine. 2023;18:6901-6914.
    PubMed    
    Abstract available

  27. GUO H, Feng S, Li Z, Yin Y, et al
    Prognostic Value of Body Composition and Systemic Inflammatory Markers in Patients with Locally Advanced Cervical Cancer Following Chemoradiotherapy.
    J Inflamm Res. 2023;16:5145-5156.
    PubMed    
    Abstract available

  28. HUANG H, Pan Y, Huang J, Zhang C, et al
    Patient-derived organoids as personalized avatars and a potential immunotherapy model in cervical cancer.
    iScience. 2023;26:108198.
    PubMed    
    Abstract available

  29. LIU B, Wu Y, Sun L, Guo C, et al
    Dosimetry and plan parameters study of three-dimensional-printed template-based intra-cavitary/interstitial interpolation technology using computed tomography-guided high-dose-rate brachytherapy in locally advanced cervical cancer.
    J Contemp Brachytherapy. 2023;15:325-333.
    PubMed    
    Abstract available

  30. JAYARATHNA S, Hoang M, Badkul R, Hoover A, et al
    Dosimetric impact of applicator displacement on three-dimensional image-guided high-dose-rate brachytherapy treatments for cervical cancer.
    J Contemp Brachytherapy. 2023;15:334-343.
    PubMed    
    Abstract available

  31. UMEMMUO MU, Eleje GU, Oluwasola TA, Ezeanochie M, et al
    Improving Treatment Outcome for Cervical Cancer Using 2-Point Assessment of Quality of Life Among Nigerian Women: A Protocol for a Multi-Center Study.
    Clin Med Insights Oncol. 2023;17:11795549231212339.
    PubMed    
    Abstract available

  32. GUANI B, Chacon E, Fanfani F, Bizzarri N, et al
    Editorial: Lymph node assessment in cervical cancer.
    Front Oncol. 2023;13:1324654.
    PubMed    


  33. TANG X, Zhou S, Zhang X, Hua K, et al
    Comparison of the survival outcomes of laparoscopic, abdominal and gasless laparoscopic radical hysterectomy for early-stage cervical cancer: trial protocol of a multicenter randomized controlled trial (LAGCC trial).
    Front Oncol. 2023;13:1287697.
    PubMed    
    Abstract available

  34. BOATMAN D, Kennedy-Rea S, Cottrell L, Hazard-Jenkins H, et al
    Cancer Screening Behaviors and Associations with Childhood Trauma, Resiliency, and Patient-Provider Relationships: Findings from an Exploratory Study of Appalachian Cervical Cancer Survivors.
    J Appalach Health. 2023;5:22-37.
    PubMed    
    Abstract available

  35. EBADI SHARAFABAD B, Abdoli A, Panahi M, Abdolmohammadi Khiav L, et al
    Anti-tumor Effects of Cisplatin Synergist in Combined Treatment with Clostridium novyi-NT Spores Against Hypoxic Microenvironments in a Mouse Model of Cervical Cancer Caused by TC-1 Cell Line.
    Adv Pharm Bull. 2023;13:817-826.
    PubMed    
    Abstract available

  36. WIJERATNE Y, Hapuachchige C
    Surgical Outcomes in Early-Stage Cervical Cancer Following Radical Hysterectomy in a Resource-Limited Setting: The Experience of the National Cancer Institute (Apeksha Hospital, Maharagama), Sri Lanka.
    Cureus. 2023;15:e47744.
    PubMed    
    Abstract available

  37. BATMAN SH, Varon ML, Daheri M, Ogburn T, et al
    Addressing cervical cancer disparities in Texas: Expansion of a community-based prevention initiative for medically underserved populations.
    Prev Med Rep. 2023;36:102486.
    PubMed    
    Abstract available

  38. LI Z, He H, Ren X, Chen Y, et al
    APOBEC3A suppresses cervical cancer via apoptosis.
    J Cancer. 2023;14:3429-3443.
    PubMed    
    Abstract available

  39. LI M, Wang D, Huang J, Luan S, et al
    Sexual Behaviors and Intimate Relationships of Sexual Partners of Young Patients with Early-Stage Cervical Cancer: A Qualitative Study.
    Int J Gen Med. 2023;16:5377-5387.
    PubMed    
    Abstract available

  40. DAMTIE S, Legese B, Berhan A, Kiros T, et al
    Knowledge, attitude, and practice of cervical cancer screening and its associated risk factors among family planning service users at Debre Tabor town health facilities, North Central Ethiopia: A cross-sectional study.
    SAGE Open Med. 2023;11:20503121231208654.
    PubMed    
    Abstract available

  41. WIJAYANTI KE, Schutze H, Mac Phail C, Ivers R, et al
    Exploring Parents' Decisions Regarding HPV Vaccination for Their Daughters in Jakarta, Indonesia: A Qualitative Study.
    Asian Pac J Cancer Prev. 2023;24:3993-3998.
    PubMed    
    Abstract available

  42. DEVI S, Joshi S
    The Effect of Multimodal Interventions Regarding Early Cervical Cancer Diagnosis on the Women's Knowledge, Attitude and Participation in Cervical Screening Program.
    Asian Pac J Cancer Prev. 2023;24:3949-3956.
    PubMed    
    Abstract available

  43. ARI A, Uysal E, Ozer H, Kilincer A, et al
    Metastatic breast cancer in the uterine cervix.
    Br J Hosp Med (Lond). 2023;84:1.
    PubMed    


  44. MARINO JM, Nunes LMP, Ali YCMM, Tonhi LDC, et al
    Educational interventions for cervical cancer prevention: a scoping review.
    Rev Bras Enferm. 2023;76:e20230018.
    PubMed    
    Abstract available

  45. ZHENG Y, Liu J, Beeraka NM, Manogaran P, et al
    Inflammation and Stem Cell Stochasticity of HPV-induced Cervical Cancer: Epigenetics Based Biomarkers through Microbiome and Metabolome for Personalized Medicine: A Systematic Review.
    Curr Med Chem. 2023 Nov 24. doi: 10.2174/0109298673257429231108072717.
    PubMed    
    Abstract available

  46. ZHU X, Ye L, Fu Y, You B, et al
    Radical hysterectomy with preoperative conization in early-stage cervical cancer: a systematic review and pairwise and network meta-analysis.
    J Minim Invasive Gynecol. 2023 Nov 26:S1553-4650(23)00975.
    PubMed    
    Abstract available

  47. ELVATUN S, Knoors D, Nygard M, Uuskula A, et al
    Cross-population evaluation of cervical cancer risk prediction algorithms.
    Int J Med Inform. 2023;181:105297.
    PubMed    
    Abstract available

  48. LIU L, Gu K, Hua D
    HDAC1 suppresses radiotherapy sensitivity in cervical cancer via regulating HIF-1alpha/VEGF signaling pathway.
    Cell Mol Biol (Noisy-le-grand). 2023;69:132-140.
    PubMed    
    Abstract available

  49. WINER RL, Lin J, Anderson ML, Tiro JA, et al
    Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial.
    JAMA. 2023;330:1971-1981.
    PubMed    
    Abstract available

  50. FA XY, Yang YJ, Niu CC, Yu YJ, et al
    Development and validation of a nomogram to predict overall survival for cervical adenocarcinoma: A population-based study.
    Medicine (Baltimore). 2023;102:e36226.
    PubMed    
    Abstract available

  51. CHEN H, Zhong Q, Liu Y, Li J, et al
    A prospective single-arm study on the relationship between dose-volume parameters of pelvic functional bone marrow and acute hematological toxicities during intensity-modulated radiotherapy with or without concurrent chemotherapy for uterine cervical/
    Radiat Oncol. 2023;18:193.
    PubMed    
    Abstract available

  52. EASTMENT MC, Wanje G, Richardson BA, Mwaringa E, et al
    Results of a cluster randomized trial testing the Systems Analysis and Improvement Approach to increase cervical cancer screening in family planning clinics in Mombasa County, Kenya.
    Implement Sci. 2023;18:66.
    PubMed    
    Abstract available

  53. LACIKA JL, Wabinga H, Kagaayi J, Opito R, et al
    Diagnostic and pre-treatment intervals among patients with cervical cancer attending care at the Uganda Cancer Institute: a cross-sectional study.
    BMC Womens Health. 2023;23:633.
    PubMed    
    Abstract available

  54. VERBERCKMOES B, De Vos T, Maelegheer K, Ali-Risasi C, et al
    Evaluation of the applicability of internal controls on self-collected samples for high-risk human papillomavirus is needed.
    BMC Womens Health. 2023;23:635.
    PubMed    
    Abstract available

  55. STANIETZKY N, Bednarski B, Shafer A, Taggart MW, et al
    Rectal Adenocarcinoma Presenting as a Cervical Mass: A Case Report.
    Am J Case Rep. 2023;24:e941884.
    PubMed    
    Abstract available

  56. ZHOU J, Lei N, Qin B, Chen M, et al
    Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation.
    Cancer Biol Ther. 2023;24:2287128.
    PubMed    
    Abstract available

  57. WENDEL SO, Snow JA, Gu L, Banerjee NS, et al
    The potential of PCNA inhibition as a therapeutic strategy in cervical cancer.
    J Med Virol. 2023;95:e29244.
    PubMed    
    Abstract available

  58. MOLINA MA, Melchers WJG
    Methodological and analytical challenges in microbiome-HPV association studies.
    J Med Virol. 2023;95:e29260.
    PubMed    


  59. BORELLA F, Gallio N, Mangherini L, Cassoni P, et al
    Recent advances in treating female genital human papillomavirus related neoplasms with topical imiquimod.
    J Med Virol. 2023;95:e29238.
    PubMed    
    Abstract available

  60. TRZESZCZ M, Mazurec M, Jach R, Mazurec K, et al
    p16/Ki67 dual stain triage versus cytology in primary human papillomavirus-based cervical cancer screening with limited genotyping.
    J Med Virol. 2023;95:e29271.
    PubMed    
    Abstract available

  61. STROBEL TD, Weber M, Heber N, Holzer A, et al
    Revisiting the role of endogenous STAT3 in HPV-positive cervical cancer cells.
    J Med Virol. 2023;95:e29230.
    PubMed    
    Abstract available

  62. HUANG X, Huo L, Xiao B, Ouyang Y, et al
    Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer.
    Cell Death Differ. 2023 Nov 25. doi: 10.1038/s41418-023-01242.
    PubMed    
    Abstract available

  63. VERMA ML, Sharma P, Singh U, Sachan R, et al
    Comparison of acceptability & efficacy of thermal ablation (thermocoagulation) & cryotherapy in VIA positive cervical lesions: A pilot study.
    Indian J Med Res. 2023;158:423-431.
    PubMed    
    Abstract available

  64. GORGONE M, Squeri A, Cuffari S, Fauci V, et al
    Rates of Primary and Secondary Prevention of Cervical Cancer: A Study in a Province in the South of Italy.
    Vaccines (Basel). 2023;11:1688.
    PubMed    
    Abstract available

  65. MAEHAMA T, Shimada S, Sakamoto J, Shibata T, et al
    Chemical Peeling Therapy Using Phenol for the Cervico-Vaginal Intraepithelial Neoplasia.
    Viruses. 2023;15:2219.
    PubMed    
    Abstract available

  66. ABDELHAFEZ OH, Abdel-Rahman IM, Alaaeldin E, Refaat H, et al
    Pro-Apoptotic Activity of Epi-Obtusane against Cervical Cancer: Nano Formulation, In Silico Molecular Docking, and Pharmacological Network Analysis.
    Pharmaceuticals (Basel). 2023;16:1578.
    PubMed    
    Abstract available

  67. LIU X, Yang R, Xiong T, Yang X, et al
    CBCT-to-CT Synthesis for Cervical Cancer Adaptive Radiotherapy via U-Net-Based Model Hierarchically Trained with Hybrid Dataset.
    Cancers (Basel). 2023;15:5479.
    PubMed    
    Abstract available

  68. SORBYE SW, Falang BM, Botha MH, Snyman LC, et al
    Enhancing Cervical Cancer Prevention in South African Women: Primary HPV mRNA Screening with Different Genotype Combinations.
    Cancers (Basel). 2023;15:5453.
    PubMed    
    Abstract available

  69. LIU J, Tang L, Chu W, Wei L, et al
    Cellular Retinoic Acid Binding Protein 2 (CRABP2), Up-regulated by HPV E6/E7, Leads to Aberrant Activation of the Integrin beta1/FAK/ERK Signaling Pathway and Aggravates the Malignant Phenotypes of Cervical Cancer.
    Biochem Genet. 2023 Nov 24. doi: 10.1007/s10528-023-10568.
    PubMed    
    Abstract available

  70. XUE Y, Zheng X, Wu G, Wang J, et al
    Rapid diagnosis of cervical cancer based on serum FTIR spectroscopy and support vector machines.
    Lasers Med Sci. 2023;38:276.
    PubMed    
    Abstract available

  71. DINCER N, Ugurluer G, Mustafayev TZ, Serkizyan A, et al
    Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer.
    Brachytherapy. 2023 Nov 23:S1538-4721(23)01644.
    PubMed    
    Abstract available

  72. MCCARTNEY M
    Calls for cervical screening should treat women like adults.
    BMJ. 2023;383:2772.
    PubMed    


  73. MABUCHI S, Komura N, Sasano T, Sakata M, et al
    Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer.
    Curr Oncol. 2023;30:9428-9436.
    PubMed    
    Abstract available

  74. PALUMBO M, Della Corte L, Ronsini C, Guerra S, et al
    Surgical Treatment for Early Cervical Cancer in the HPV Era: State of the Art.
    Healthcare (Basel). 2023;11:2942.
    PubMed    
    Abstract available

  75. LI S, Huang M, Zhu Y, Zeng H, et al
    Temporal trends in incidence and mortality of cervical cancer in China from 1990 to 2019 and predictions for 2034.
    Eur J Cancer Prev. 2023 Nov 6. doi: 10.1097/CEJ.0000000000000849.
    PubMed    
    Abstract available

  76. COWLING A, Nevens L, Contogiorgi N, Bradley N, et al
    Developing and piloting an intervention to reduce colposcopy non-attendance and corresponding inequalities: a mixed-methods study.
    Lancet. 2023;402 Suppl 1:S35.
    PubMed    
    Abstract available

  77. LIN R, Jin H, Fu X
    Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis.
    Expert Rev Vaccines. 2023;22:1168-1178.
    PubMed    
    Abstract available

  78. TIEN CT, Ding DC
    Adenomyoma recurrence 7 years after laparoscopic supracervical hysterectomy: A case report and literature review.
    Medicine (Baltimore). 2023;102:e36089.
    PubMed    
    Abstract available

  79. WANG P, Yang B, Huang H, Liang P, et al
    HIV gp120/Tat protein-induced epithelial-mesenchymal transition promotes the progression of cervical lesions.
    AIDS Res Ther. 2023;20:82.
    PubMed    
    Abstract available

  80. PALMER C, Tobe K, Negishi Y, You X, et al
    Health impact and cost effectiveness of implementing gender-neutral HPV vaccination in Japan.
    J Med Econ. 2023;26:1546-1554.
    PubMed    
    Abstract available

  81. MVUNDURA M, Slavkovsky R, Debellut F, Naddumba T, et al
    Cost and operational context for national human papillomavirus (HPV) vaccine delivery in six low- and middle-income countries.
    Vaccine. 2023 Nov 8:S0264-410X(23)01306-3. doi: 10.1016/j.vaccine.2023.
    PubMed    
    Abstract available

  82. QIN F, Pang H, Ma J, Xu H, et al
    The value of multiparametric MRI combined with clinical prognostic parameters in predicting the 5-year survival of stage IIIC1 cervical squamous cell carcinoma.
    Eur J Radiol. 2023;169:111181.
    PubMed    
    Abstract available

  83. FOWLER JR, Maani EV, Dunton CJ, Gasalberti DP, et al
    Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol.
    J Mol Diagn. 2023;25:957-966.
    PubMed    
    Abstract available

  84. ZHENG X, Hu N, Liu J, Zhao K, et al
    Cervicovaginal microbiota disorder combined with the change of cytosine phosphate guanine motif- toll like receptor 9 axis was associated with cervical cancerization.
    J Cancer Res Clin Oncol. 2023;149:17371-17381.
    PubMed    
    Abstract available

  85. DO AMARAL CC, Castro PT, Frota R, de Freitas Lima LAC, et al
    Vaginal leiomyoma: Advantages of clinical sonovaginography and ultrasound dynamic evaluation of uterine cervix-related lesions.
    J Clin Ultrasound. 2023;51:1509-1511.
    PubMed    
    Abstract available

  86. NAKAGAWA S, Yagi A, Ueda Y, Ikeda S, et al
    Intentions for catch-up HPV vaccination in Japan: an internet survey.
    Int J Clin Oncol. 2023;28:1667-1679.
    PubMed    
    Abstract available

  87. LEUNG SOA, Villa A, Duffey-Lind E, Welch K, et al
    An Interactive Educational Tool to Improve Human Papillomavirus Vaccine Knowledge and Recommendation Among Nurses.
    J Cancer Educ. 2023;38:1880-1886.
    PubMed    
    Abstract available

  88. LYCKE KD, Kahlert J, Damgaard RK, Eriksen DO, et al
    Clinical course of cervical intraepithelial neoplasia grade 2: a population-based cohort study.
    Am J Obstet Gynecol. 2023;229:656.
    PubMed    
    Abstract available

  89. OYA K, Kondo Y, Kishino M, Toyosawa S, et al
    Cytological features of oral malignant lymphoma in scraping liquid-based cytology: Cases of plasmablastic lymphoma and anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Ann Diagn Pathol. 2023;67:152180.
    PubMed    
    Abstract available

  90. PETRAS M, Dvorak V, Lomozova D, Macalik R, et al
    Timing of HPV vaccination as adjuvant treatment of CIN2+ recurrence in women undergoing surgical excision: a meta-analysis and meta-regression.
    Sex Transm Infect. 2023 Aug 8:sextrans-2023-055793.
    PubMed    
    Abstract available

  91. GUNN CM, Berrian K, Weiss JE, Tosteson AAN, et al
    A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Prev Med. 2023;175:107649.
    PubMed    
    Abstract available

  92. NAMBA M, Kaneda Y, Kotera Y
    Breaking down the stigma: reviving the HPV vaccination trust in Japan.
    QJM. 2023;116:895-896.
    PubMed    


  93. KASHOFER K, Reich O, Regauer S
    Acquisition of Genetic Aberrations During the Progression of High-Grade Intraepithelial Lesions/Micro-Invasive Squamous Cancers to Widely Invasive Cervical Squamous Cell Cancer.
    Arch Pathol Lab Med. 2023;147:1438-1445.
    PubMed    
    Abstract available

  94. LOPEZ-CARDENAS MT, Jimenez A, Espinosa-Montesinos A, Maldonado-Alvarado E, et al
    Elimination of Human Papillomavirus and Cervical Pathological Microbiota with Photodynamic Therapy in Women from Mexico City with Cervical Intraepithelial Neoplasia I.
    Photochem Photobiol. 2023;99:1468-1475.
    PubMed    
    Abstract available

  95. KULAKSIZ D, Bayoglu Tekin Y, Deger O, Baki Erin K, et al
    Investigating the relationship between the cervical mucoprotein levels and cervical intraepithelial neoplasia.
    Minerva Obstet Gynecol. 2023;75:559-564.
    PubMed    
    Abstract available

  96. XIANG X, Ding J
    Anoikis Patterns in Cervical Cancer: Identification of Subgroups and Construction of a Novel Risk Model for Predicting Prognosis and Immune Response.
    Front Biosci (Landmark Ed). 2023;28:287.
    PubMed    
    Abstract available

  97. TAO W, Wang W, Zhai J, Guo L, et al
    Efficacy Analysis of Neoadjuvant versus Adjuvant Cisplatin-Paclitaxel Regimens for Initial Treatment of FIGO Stages IB3 and IIA2 Cervical Cancer.
    Med Sci Monit. 2023;29:e940545.
    PubMed    
    Abstract available

  98. CAO DM, Liu T
    Exploration of the Mechanism of Kaempferol in the Treatment of Cervical Cancer-based on Metabolomics and Network Pharmacology.
    Curr Pharm Des. 2023 Dec 7. doi: 10.2174/0113816128268061231012073704.
    PubMed    
    Abstract available


  99. Human papillomavirus vaccination and cervical cancer risk.
    BMJ. 2023;383:p2901.
    PubMed    


  100. NI S, Wei Z, Li D
    Effect of lncRNA LINC00324 on cervical cancer progression through down-regulation of miR-195-5p.
    J Obstet Gynaecol. 2023;43:2285384.
    PubMed    
    Abstract available

  101. HERNANDEZ-ESPARZA MJ, Fratoddi I, Cerra S, Juarez-Moreno K, et al
    Hybrid AuNPs-3MPS-MTX nanosystem and its evaluation for treating cervical cancer and melanoma.
    Nanoscale Adv. 2023;5:7077-7085.
    PubMed    
    Abstract available

  102. ZHOU T, Xiao Z, Lu J, Zhang L, et al
    IGF2BP3-mediated regulation of GLS and GLUD1 gene expression promotes treg-induced immune escape in human cervical cancer.
    Am J Cancer Res. 2023;13:5289-5305.
    PubMed    
    Abstract available

  103. KALBHOR M, Shinde S, Wajire P, Jude H, et al
    CerviCell-detector: An object detection approach for identifying the cancerous cells in pap smear images of cervical cancer.
    Heliyon. 2023;9:e22324.
    PubMed    
    Abstract available

  104. LI S, Shen H, Wan Q, Chen P, et al
    Downregulation of HS6ST2 Inhibits Cervical Cancer Cell Migration and Invasion in Vivo and in Vitro.
    Discov Med. 2023;35:1147-1159.
    PubMed    
    Abstract available

  105. TAN B, Wikan N, Lin S, Thaklaewphan P, et al
    Inhibitory actions of oxyresveratrol on the PI3K/AKT signaling cascade in cervical cancer cells.
    Biomed Pharmacother. 2023;170:115982.
    PubMed    
    Abstract available

  106. BRUNO M, Bizzarri N, Teodorico E, Certelli C, et al
    The potential role of systemic inflammatory markers in predicting recurrence in early-stage cervical cancer.
    Eur J Surg Oncol. 2023;50:107311.
    PubMed    
    Abstract available

  107. PANAYIOTOU T, Eftychiou M, Patera E, Promponas VJ, et al
    A paradigm for post-embryonic Oct4 re-expression: E7-induced hydroxymethylation regulates Oct4 expression in cervical cancer.
    J Med Virol. 2023;95:e29264.
    PubMed    
    Abstract available

  108. HEBER N, Kuhn BJ, Strobel TD, Lohrey C, et al
    The impact of cycling hypoxia on the phenotype of HPV-positive cervical cancer cells.
    J Med Virol. 2023;95:e29280.
    PubMed    
    Abstract available

  109. SCOTT-WILLIAMS J, Hosein A, Akpaka P, Adidam Venkata CR, et al
    Epidemiology of Cervical Cancer in the Caribbean.
    Cureus. 2023;15:e48198.
    PubMed    
    Abstract available

  110. HACISEYITOGLU AO, Dogan TC, Dilsiz SA, Canpinar H, et al
    Pitavastatin induces caspase-mediated apoptotic death through oxidative stress and DNA damage in combined with cisplatin in human cervical cancer cell line.
    J Appl Toxicol. 2023 Dec 6. doi: 10.1002/jat.4565.
    PubMed    
    Abstract available

  111. ZHANG P, Tang Y, Zhao J, Yang J, et al
    TRIM11 regulated by m6A modification promotes the progression of cervical cancer by PHLPP1 ubiquitination.
    Neoplasma. 2023;70:659-669.
    PubMed    
    Abstract available

  112. BRAKEBILL A, Morgan A, Lieberman RW
    Primary HPV Screening vs Cotesting for Cervical Cancer.
    JAMA. 2023;330:2121.
    PubMed    


  113. PERKINS RB, Wentzensen N, Schiffman M
    Primary HPV Screening vs Cotesting for Cervical Cancer-Reply.
    JAMA. 2023;330:2121-2122.
    PubMed    


  114. ZHANG H, Cai S, Xia Y, Lin Y, et al
    Association between human herpesvirus infection and cervical carcinoma: a systematic review and meta-analysis.
    Virol J. 2023;20:288.
    PubMed    
    Abstract available

  115. SMAHEL M, Nunvar J
    Bioinformatics analysis of immune characteristics in tumors with alternative carcinogenesis pathways induced by human papillomaviruses.
    Virol J. 2023;20:287.
    PubMed    
    Abstract available

  116. KOSITAMONGKOL C, Kanchanasurakit S, Mepramoon E, Talungchit P, et al
    Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand.
    BMC Public Health. 2023;23:2413.
    PubMed    
    Abstract available

  117. BEL HAJ RHOUMA R, Ardhaoui M, Othman H, Ben Jemia Z, et al
    The E6 gene polymorphism of Human papillomavirus 16 in relation to the risk of cervical cancer in Tunisian women.
    Infect Genet Evol. 2023;116:105536.
    PubMed    
    Abstract available

  118. LI K, Chen J, Hu Y, Wang YZ, et al
    Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial.
    Lancet Oncol. 2023 Dec 1:S1470-2045(23)00531.
    PubMed    
    Abstract available

  119. PAUTIER P
    Is there finally a place for neoadjuvant treatment in locally advanced cervical cancer?
    Lancet Oncol. 2023 Dec 1:S1470-2045(23)00576.
    PubMed    


  120. OAKNIN A, Gladieff L, Martinez-Garcia J, Villacampa G, et al
    Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
    Lancet. 2023 Dec 1:S0140-6736(23)02405-4. doi: 10.1016/S0140-6736(23)02405.
    PubMed    
    Abstract available

  121. MILESHKIN LR, Manoharan S
    Improving survival from metastatic, recurrent, or persistent cervical cancer.
    Lancet. 2023 Dec 1:S0140-6736(23)02690-9. doi: 10.1016/S0140-6736(23)02690.
    PubMed    


  122. WILDING S, O'Connor DB, Conner M
    Social Norms in Cervical Cancer Screening.
    Psychol Rep. 2023 Dec 4:332941231219943. doi: 10.1177/00332941231219943.
    PubMed    
    Abstract available

  123. YADAV S, Jayaseelan V, Pandjatcharam J, Roy G, et al
    Facilitators and Challenges in Patient's Satisfaction with Quality of Cervical Cancer Care in a Tertiary Care Hospital, Puducherry, India: A Qualitative Study.
    South Asian J Cancer. 2023;12:250-255.
    PubMed    
    Abstract available

  124. TIE W, Ge F
    Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expression.
    PeerJ. 2023;11:e16451.
    PubMed    
    Abstract available

  125. ZHANG Q, Zhang J, Liu Z, Wang J, et al
    Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy.
    Drug Des Devel Ther. 2023;17:3507-3522.
    PubMed    
    Abstract available

  126. SUDHAKAR K, Saravanan D, Hariharan G, Sanaj MS, et al
    Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer.
    Open Life Sci. 2023;18:20220770.
    PubMed    
    Abstract available

  127. NHANGAVE AV, Evaristo B, Osorio D, Muhiwa A, et al
    Knowledge about Cervical Cancer Prevention and Screening in Women with Cervical Cancer Attending Gynecological Services in Southern Mozambique.
    Niger J Clin Pract. 2023;26:1616-1620.
    PubMed    
    Abstract available

  128. FENG S, Wang Z, Zhang H, Hou B, et al
    Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
    J Gene Med. 2023 Dec 4:e3643. doi: 10.1002/jgm.3643.
    PubMed    
    Abstract available

  129. ELLIS SJ
    Are women-who-have-sex-with-women an 'at-risk' group for cervical cancer? An exploratory study of women in Aotearoa New Zealand.
    Sex Health. 2023 Dec 4. doi: 10.1071/SH23145.
    PubMed    
    Abstract available

  130. BELANGER C, Aubin S, Lavallee MC, Beaulieu L, et al
    Simultaneous catheter and multicriteria optimization for HDR cervical cancer brachytherapy with a complex intracavity/interstitial applicator.
    Med Phys. 2023 Dec 3. doi: 10.1002/mp.16874.
    PubMed    
    Abstract available

  131. MORSE RM, Brown J, Gage JC, Prieto BA, et al
    "Easy women get it": pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program.
    BMC Public Health. 2023;23:2396.
    PubMed    
    Abstract available

  132. KIENDREBEOGO JA, Sidibe ARO, Compaore GB, Nacanabo R, et al
    Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study.
    BMC Health Serv Res. 2023;23:1338.
    PubMed    
    Abstract available

  133. WU Q, Qian M, Welby S, Guignard A, et al
    Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018-2020.
    Hum Vaccin Immunother. 2023;19:2283912.
    PubMed    
    Abstract available

  134. WANG Y, Gong Y, Zhou Q, Qu W, et al
    Genetic variability analysis of human papillomavirus 58: Novel sublineage identification and persistent infection association.
    J Med Virol. 2023;95:e29262.
    PubMed    
    Abstract available

  135. DESAI KT, de Sanjose S, Schiffman M
    Treatment of Cervical Precancers is the Major Remaining Challenge in Cervical Screening Research.
    Cancer Prev Res (Phila). 2023;16:649-651.
    PubMed    
    Abstract available

  136. XU D, Feng H, Ren Z, Li X, et al
    SNHG3/WISP2 Axis Promotes Hela Cell Migration and Invasion via Activating Wnt/beta-Catenin Signaling.
    Cancer Genomics Proteomics. 2023;20.
    PubMed    
    Abstract available

  137. CHENG G, Wang M, Sun H, Lai J, et al
    Age at menopause is inversely related to the prevalence of common gynecologic cancers: a study based on NHANES.
    Front Endocrinol (Lausanne). 2023;14:1218045.
    PubMed    
    Abstract available

  138. SHANKAR B, Singh T, Kumar B, Arora A, et al
    Solvent-free synthesis and in-silico molecular docking study of (E)-3-(beta-C-glycosylmethylidene)-N-aryl/alkyl succinimides.
    Org Biomol Chem. 2023;21:9398-9409.
    PubMed    
    Abstract available

  139. CAI H, Chen S, Wu Z, Wang F, et al
    Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma.
    Aging (Albany NY). 2023;15:13041-13058.
    PubMed    
    Abstract available

  140. MAKONI M
    HPV vaccine roll-out in Nigeria and Bangladesh.
    Lancet Oncol. 2023;24:1311-1312.
    PubMed    


  141. SKOLNIK JM, Morrow MP
    Vaccines for HPV-associated diseases.
    Mol Aspects Med. 2023;94:101224.
    PubMed    
    Abstract available

  142. MORCET-DELATTRE R, Espenel S, Tas P, Chargari C, et al
    Role of radiotherapy in the management of rare gynaecological cancers.
    Cancer Radiother. 2023;27:778-788.
    PubMed    
    Abstract available

  143. KING J, Flores YN, Meneses-Leon J, Hernandez-Salazar S, et al
    Clinical Performance of hrHPV Primary Screening Using Vaginal versus Cervical Samples to Detect High-grade Intraepithelial Lesions.
    Cancer Prev Res (Phila). 2023;16:681-687.
    PubMed    
    Abstract available

  144. GAY SS, Kisling KD, Anderson BM, Zhang L, et al
    Identifying the optimal deep learning architecture and parameters for automatic beam aperture definition in 3D radiotherapy.
    J Appl Clin Med Phys. 2023;24:e14131.
    PubMed    
    Abstract available

  145. KOTAKA S, Kondo E, Kawai Y, Okamoto K, et al
    Paclitaxel-carboplatin plus bevacizumab therapy for advanced neuroendocrine carcinoma of the uterine cervix: A retrospective case series.
    J Obstet Gynaecol Res. 2023;49:2868-2874.
    PubMed    
    Abstract available

  146. YIN Z, Cui Z, Kang S, Ji M, et al
    Laparoscopic versus open radical hysterectomy in FIGO 2018 early-stage cervical adenocarcinoma: Long-term survival outcomes after propensity score matching.
    J Obstet Gynaecol Res. 2023;49:2849-2859.
    PubMed    
    Abstract available

  147. STOLNICU S, Allison D, Patrichi A, Flynn J, et al
    Invasive Squamous Cell Carcinoma of the Cervix: A Review of Morphological Appearances Encountered in Human Papillomavirus-associated and Papillomavirus-independent Tumors and Precursor Lesions.
    Adv Anat Pathol. 2024;31:1-14.
    PubMed    
    Abstract available

  148. WANG H, Shi Y, Sun Y, Zhang A, et al
    E7 as a Promising Biomarker for Monitoring the Progression of Cervical Lesions in Patients with HPV 16/18 Infections.
    Altern Ther Health Med. 2023;29:310-314.
    PubMed    
    Abstract available

  149. CHEN M, Xue P, Li Q, Shen Y, et al
    Enhancing colposcopy training using a widely accessible digital education tool in China.
    Am J Obstet Gynecol. 2023;229:538.
    PubMed    
    Abstract available

  150. MICHALEK IM, Manczuk M, Caetano Dos Santos FL, Macios A, et al
    Self-reported participation in cervical cancer screening among Polish women in 2004-2019.
    Ginekol Pol. 2023 Dec 15. doi: 10.5603/gpl.96634.
    PubMed    
    Abstract available

  151. NOWAKOWSKI A
    Cervical cancer - a preventable (?) disease in Poland.
    Ginekol Pol. 2023 Dec 15. doi: 10.5603/gpl.98540.
    PubMed    


  152. GOVAHI A, Zahmatkesh N, Pourbagherian O, Khas NM, et al
    Antitumor Effects of Curcumin on Cervical Cancer with the Focus on Molecular Mechanisms: An Exegesis.
    Curr Pharm Des. 2023 Dec 8. doi: 10.2174/0113816128279330231129180250.
    PubMed    
    Abstract available

  153. VALI M, Maleki Z, Nikbakht HA, Hassanipour S, et al
    Survival rate of cervical cancer in Asian countries: a systematic review and meta-analysis.
    BMC Womens Health. 2023;23:671.
    PubMed    
    Abstract available

  154. XIANG H, Tang H, He Q, Sun J, et al
    NDUFA8 is transcriptionally regulated by EP300/H3K27ac and promotes mitochondrial respiration to support proliferation and inhibit apoptosis in cervical cancer.
    Biochem Biophys Res Commun. 2023;693:149374.
    PubMed    
    Abstract available

  155. YAMAGUCHI S, Koizumi M, Kakuda M, Yamamoto T, et al
    Uncommon Hematogenous Metastasis: Orbital Involvement in Uterine Cervical Cancer.
    Am J Case Rep. 2023;24:e941076.
    PubMed    
    Abstract available

  156. TEWARI KS, Colombo N, Monk BJ, Dubot C, et al
    Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses from the KEYNOTE-826 Randomized Clinical Trial.
    JAMA Oncol. 2023 Dec 14. doi: 10.1001/jamaoncol.2023.5410.
    PubMed    
    Abstract available

  157. HU XX, Zhou LY, Lin RY
    The association between the serum concentration of CXC subfamily chemokine 13 and post-surgical clinical outcomes in cervical cancer patients.
    Eur Rev Med Pharmacol Sci. 2023;27:11635-11642.
    PubMed    
    Abstract available

  158. IMPELIDO ML, Brewer K, Burgess P, Curtis J, et al
    Age-specific differences in cervical cancer screening rates in women using mental health services in New South Wales, Australia.
    Aust N Z J Psychiatry. 2023 Dec 14:48674231217415.
    PubMed    
    Abstract available

  159. AND ALTERNATIVE MEDICINE EC
    Retracted: Analysis of the Effect of Fast Recovery Surgery Concept on Perioperative Nursing Care of Patients with Radical Resection of Cervical Cancer and Its Influence on Psychological Status.
    Evid Based Complement Alternat Med. 2023;2023:9841487.
    PubMed    
    Abstract available

  160. SCANNING
    Retracted: The Application Value of CT Three-Dimensional Microscope Reconstruction Technology in the Diagnosis of Cervical Cancer.
    Scanning. 2023;2023:9786383.
    PubMed    
    Abstract available

  161. JIA Y, Zou K, Zou L
    Research progress of metabolomics in cervical cancer.
    Eur J Med Res. 2023;28:586.
    PubMed    
    Abstract available

  162. FURUKAWA Y, Ishii M, Ando J, Ikeda K, et al
    iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer.
    Cell Rep Med. 2023 Dec 8:101327. doi: 10.1016/j.xcrm.2023.101327.
    PubMed    
    Abstract available

  163. HIMOTO Y, Yamanoi K, Kurata Y
    Survival impact of the degree of parametrial invasion on MRI in locally advanced cervical cancer.
    Eur Radiol. 2023 Dec 13. doi: 10.1007/s00330-023-10480.
    PubMed    


  164. KOMURA N, Mabuchi S, Sasano T, Kamiura S, et al
    Twenty-five-year mortality trends of four major histological subtypes of cervical cancer: a population-based study using the Osaka cancer registry data.
    Front Oncol. 2023;13:1233354.
    PubMed    
    Abstract available

  165. PRIYA A, Bhatia P, Singh N
    Study on Sociodemographic Profiles and Health-Seeking Behaviour in Cervical Cancer Patients in a Tertiary Healthcare Centre in Central India.
    Cureus. 2023;15:e48635.
    PubMed    
    Abstract available

  166. LUO Y, Ma X
    An Energy-Efficient Test and Predictive Model for Recurrence After Radiotherapy in Localized Intermediate and Advanced Cervical Cancer Were Created Using Thymidine Kinase 1 in Conjunction with Inflammatory Markers and Tumor Markers.
    Int J Gen Med. 2023;16:5789-5797.
    PubMed    
    Abstract available

  167. WANG J, Wang S, Wang J, Huang J, et al
    Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer.
    Cancer Med. 2023 Dec 12. doi: 10.1002/cam4.6734.
    PubMed    
    Abstract available

  168. BELLO ROUFAI D
    [Place of innovative therapies in the management of cervical cancer].
    Bull Cancer. 2023 Dec 11:S0007-4551(23)00429.
    PubMed    
    Abstract available

  169. VALE DB, Teixeira JC
    Implementing plans for global elimination of cervical cancer.
    Nat Med. 2023;29:3004-3005.
    PubMed    


  170. DU NH, Ngoc TTB, Cang HQ, Luyen NTT, et al
    KTt-45, a T-type calcium channel blocker, acts as an anticancer agent by inducing apoptosis on HeLa cervical cancer cell line.
    Sci Rep. 2023;13:22092.
    PubMed    
    Abstract available

  171. ELFSTROM M, Gray PG, Dillner J
    Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic.
    Elife. 2023;12:e80905.
    PubMed    
    Abstract available

  172. YANG C, Zhang Y, Wang R, Cheng B, et al
    IL-10(+)CD19(+) regulatory B cells induce CD4(+)Foxp3(+)regulatory T cells in serum of cervical cancer patients.
    Autoimmunity. 2024;57:2290909.
    PubMed    
    Abstract available

  173. SAUL H, Cassidy S, Imison C, Athanasiou A, et al
    Preventing cervical cancer: what are the risks and benefits of different treatments?
    BMJ. 2023;383:p2802.
    PubMed    
    Abstract available

  174. TEIXEIRA AR, Abreu MH
    Metastatic Cervical Cancer: A Case That Recalls the Importance of a Multidisciplinary Approach.
    Cureus. 2023;15:e48626.
    PubMed    
    Abstract available

  175. TOFT MOREN A, Bull C, Bergmark K
    Remarkable effects of infliximab on severe radiation-induced side effects in a patient with uterine cervical cancer: a case report.
    J Int Med Res. 2023;51:3000605231208596.
    PubMed    
    Abstract available

  176. SHA Y, Liu Y, Yang X, Wang J, et al
    Exploring the diagnostic potential of EPB41L3 methylation in cervical cancer and precancerous lesions: A systematic review and meta-analysis.
    Gynecol Obstet Invest. 2023 Dec 11. doi: 10.1159/000535563.
    PubMed    
    Abstract available

  177. ABU-RUSTUM NR, Yashar CM, Arend R, Barber E, et al
    NCCN Guidelines(R) Insights: Cervical Cancer, Version 1.2024.
    J Natl Compr Canc Netw. 2023;21:1224-1233.
    PubMed    
    Abstract available

  178. ASADZADEH A, Ghorbani N, Dastan K
    Identification of druggable hub genes and key pathways associated with cervical cancer by protein-protein interaction analysis: An in silico study.
    Int J Reprod Biomed. 2023;21:809-818.
    PubMed    
    Abstract available

  179. SAITO T, Murakami M, Sumiya T, Kobayashi D, et al
    Multimodal treatment with chemoradiotherapy, regional hyperthermia and interstitial brachytherapy for a huge locally advanced cervical cancer: A case report.
    Tech Innov Patient Support Radiat Oncol. 2023;28:100222.
    PubMed    
    Abstract available

  180. LIN C, Yang F, Guo B, Xiao N, et al
    Development of a combined model incorporating clinical characteristics and magnetic resonance imaging features to enhance the predictive value of a prognostic model for locally advanced cervical cancer.
    Front Oncol. 2023;13:1284493.
    PubMed    
    Abstract available

  181. LIU X, Zhu Y, Huang S, Shi T, et al
    Multiomics analysis of metabolic heterogeneity in cervical cancer cell lines with or without HPV.
    Front Oncol. 2023;13:1194462.
    PubMed    
    Abstract available

  182. SAKRAWAL K, Meena G, Gupta A, Malav K, et al
    Knowledge, attitude, and practice about cervical cancer among adult women in rural Jaipur: An observational analysis.
    J Family Med Prim Care. 2023;12:2379-2384.
    PubMed    
    Abstract available

  183. LIAO L, Huang P, Zhao J, Wang Z, et al
    lncRNA799/TBL1XR1/ZEB1 Axis Forms a Feedback Loop to Promote the Epithelial-Mesenchymal Transition of Cervical Cancer Cells.
    Crit Rev Eukaryot Gene Expr. 2024;34:33-43.
    PubMed    
    Abstract available

  184. AVISHA M, Pelupessy NU, Rahman A, Rauf S, et al
    Pre-treatment inflammatory and immune system parameters predicting cervical cancer metastasis.
    Turk J Obstet Gynecol. 2023;20:285-292.
    PubMed    
    Abstract available

  185. FELTRI G, Valenti G, Isidoro E, Kaur J, et al
    Evaluation of self-sampling-based cervical cancer screening strategy using HPV Selfy CE-IVD test coupled with home-collection kit: a clinical study in Italy.
    Eur J Med Res. 2023;28:582.
    PubMed    
    Abstract available

  186. GARCIA E, Ayoub N, Tewari KS
    Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer.
    J Gynecol Oncol. 2023 Nov 30. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  187. PAVONE M, Goglia M, Scambia G, Querleu D, et al
    Laparoscopic-Assisted Vaginal Trachelectomy with Prophylactic Cerclage: A Safe Fertility-Sparing Treatment for Early Stage Cervical Cancer.
    Ann Surg Oncol. 2023 Dec 10. doi: 10.1245/s10434-023-14737.
    PubMed    
    Abstract available

  188. LIAO YQ, Fang BB, Wu QX, Dong WY, et al
    Verapamil modulates NFAT2 to inhibit tumor growth and potentiates PD1ab immune checkpoint inhibitor therapy in cervical cancer treatment.
    J Recept Signal Transduct Res. 2023.
    PubMed    
    Abstract available

  189. SONG H, Qiu J, Hua K
    USP14 promotes the proliferation of cervical cancer via upregulating beta-catenin.
    Environ Toxicol. 2023 Dec 9. doi: 10.1002/tox.23990.
    PubMed    
    Abstract available

  190. ZHANG J, Zhou Y, Ye H, Chen C, et al
    Effect of laparoscopic-assisted transvaginal hysterectomy on wound complications in patients with early stage cervical cancer: A meta-analysis.
    Int Wound J. 2023 Dec 8. doi: 10.1111/iwj.14529.
    PubMed    
    Abstract available

  191. DAU H, Zhou C, Nankya E, Naguti P, et al
    The burden of travelling for cervical cancer treatment in Uganda: A mixed-method study.
    Trop Med Int Health. 2023 Dec 8. doi: 10.1111/tmi.13958.
    PubMed    
    Abstract available

  192. ZHANG S, Chen M, Geng Z, Liu T, et al
    Potential Application of Self-Assembled Peptides and Proteins in Breast Cancer and Cervical Cancer.
    Int J Mol Sci. 2023;24:17056.
    PubMed    
    Abstract available

  193. MENESES-URREA LA, Vaquero-Abellan M, Villegas Arenas D, Benachi Sandoval N, et al
    Association between Cervical Cancer and Dietary Patterns in Colombia.
    Nutrients. 2023;15:4889.
    PubMed    
    Abstract available

  194. YANG Z, Liu Z, Ablise M, Maimaiti A, et al
    Design and Synthesis of Novel alpha-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells.
    Molecules. 2023;28:7697.
    PubMed    
    Abstract available

  195. YE M, Liu T, Miao L, Zou S, et al
    The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models.
    Cancers (Basel). 2023;15:5625.
    PubMed    
    Abstract available

  196. MOHAMMED FA, Tune KK, Jett M, Muhie S, et al
    Cervical Cancer Stages, Human Papillomavirus Integration, and Malignant Genetic Mutations: Integrative Analysis of Datasets from Four Different Cohorts.
    Cancers (Basel). 2023;15:5595.
    PubMed    
    Abstract available

  197. MONTOYA-GOMEZ A, Tonello F, Spolaore B, Massimino ML, et al
    Pllans-II: Unveiling the Action Mechanism of a Promising Chemotherapeutic Agent Targeting Cervical Cancer Cell Adhesion and Survival Pathways.
    Cells. 2023;12:2715.
    PubMed    
    Abstract available

  198. MALI ME, Sanyang O, Harris KL, Sorensen J, et al
    Capacity assessment and spatial analysis of cervical cancer services in The Gambia.
    BMC Womens Health. 2023;23:660.
    PubMed    
    Abstract available

  199. KANG M, Qiu J, Wei H, Li J, et al
    A bibliometric analysis of global research trends of inflammation in cervical cancer: A review.
    Medicine (Baltimore). 2023;102:e36598.
    PubMed    
    Abstract available

  200. WU J, Wang X, Xiao L
    Nodular fasciitis of the abdominal wall complicating radiotherapy for cervical cancer: A case report.
    Asian J Surg. 2023 Dec 7:S1015-9584(23)01931.
    PubMed    


  201. BRAVO CA, Walker MJ, Papadopoulos A, McWhirter JE, et al
    Social media use in HPV-, cervical cancer-, and cervical screening-related research: A scoping review.
    Prev Med. 2023 Dec 6:107798. doi: 10.1016/j.ypmed.2023.107798.
    PubMed    
    Abstract available

  202. YE Y, Li M, Pan Q, Fang X, et al
    Machine learning-based classification of deubiquitinase USP26 and its cell proliferation inhibition through stabilizing KLF6 in cervical cancer.
    Comput Biol Med. 2023;168:107745.
    PubMed    
    Abstract available


  203. HPV ctDNA Allows for the Detection of Residual Disease in Cervical Cancer.
    Cancer Discov. 2023 Dec 8:OF1. doi: 10.1158/2159-8290.CD-RW2023.
    PubMed    
    Abstract available

  204. VAHABI M, Shahil-Feroz A, Lofters A, Wong JP, et al
    Surviving the Storm: The Impact of COVID-19 on Cervical Cancer Screening in Low- and Middle-Income Countries.
    Healthcare (Basel). 2023;11:3079.
    PubMed    
    Abstract available

  205. KHADRAOUI W, Meade CE, Backes FJ, Felix AS, et al
    Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic Cancer.
    JAMA Netw Open. 2023;6:e2346494.
    PubMed    
    Abstract available

  206. OUEDRAOGO RA, Kande A, Nadembega WMC, Ouermi D, et al
    Distribution of high- and low-risk human papillomavirus genotypes and their prophylactic vaccination coverage among West African women: systematic review.
    J Egypt Natl Canc Inst. 2023;35:39.
    PubMed    
    Abstract available

  207. BITTENCOURT DD, Zanine RM, Sebastiao APM, Ribas CM, et al
    Risk Factors for Persistence or Recurrence of High-Grade Cervical Squamous Intraepithelial Lesions.
    Rev Col Bras Cir. 2023;50:e20233537.
    PubMed    
    Abstract available

  208. ATIGAN A, Kilic D, Karakaya YA, Gok S, et al
    The relationship of immunohistochemical SOX-2 staining with histopathological diagnosis in patients with abnormal colposcopic findings.
    Histochem Cell Biol. 2023;160:555-561.
    PubMed    
    Abstract available

  209. GRADISSIMO A, Clarke MA, Xue X, Castle PE, et al
    A Novel HPV/Host DNA Methylation-Score and Detection of Cervical Adenocarcinoma.
    J Natl Cancer Inst. 2023 Jul 19:djad134. doi: 10.1093.
    PubMed    
    Abstract available

  210. WANG J, Zhang B, Gong S, Liu Y, et al
    Cancer susceptibility 18 positively regulates NUAK Family Kinase 1 expression to promote migration and invasion via sponging of miR-5586-5p in cervical cancer cells.
    Int J Immunopathol Pharmacol. 2023;37:3946320231223310.
    PubMed    
    Abstract available

  211. BONUCK KJ, Angier H, McCrimmon S, Holderness H, et al
    A Scoping Literature Review on Evidence-Based Strategies to Increase Cervical Cancer Screening.
    J Prim Care Community Health. 2023;14:21501319231220994.
    PubMed    
    Abstract available

  212. WANG X, Li H, Li N, Yang H, et al
    LncRNA BCRT1 depletion suppresses cervical cancer cell growth via sponging miR-432-5p/CCR7 axis.
    3 Biotech. 2024;14:17.
    PubMed    
    Abstract available

  213. LESSELIERS T, Van Trappen P
    Robotic Vaginal Cuff Closure During Radical Hysterectomy for Early-Stage Cervical Cancer: The Bruges Method.
    Cureus. 2023;15:e49149.
    PubMed    
    Abstract available

  214. MOLIKA P, Leetanaporn K, Rungkamoltip P, Roytrakul S, et al
    Proteomic analysis of small extracellular vesicles unique to cervical cancer.
    Transl Cancer Res. 2023;12:3113-3128.
    PubMed    
    Abstract available

  215. WANG G, Wang J, Momeni MR
    Epigallocatechin-3-gallate and its nanoformulation in cervical cancer therapy: the role of genes, MicroRNA and DNA methylation patterns.
    Cancer Cell Int. 2023;23:335.
    PubMed    
    Abstract available

  216. HSIEH HY, Lu CH, Wang L
    Response to Dr. Liu 's comments on definite chemoradiotherapy for early-stage "bulky" cervical cancer.
    J Formos Med Assoc. 2023 Dec 20:S0929-6646(23)00438.
    PubMed    


  217. KYEI KA, Daniels J, Broni R, Anim-Sampong S, et al
    The sexuality of women with cervical cancer undergoing definitive radiotherapy in Ghana.
    Radiography (Lond). 2023;30:332-339.
    PubMed    
    Abstract available

  218. GHAZI AA, Alturkistani HM, Alturkistani AM Jr, Alhajuj HY, et al
    Cervical Cancer Screening Barriers Among Citizens of Jeddah.
    Cureus. 2023;15:e50797.
    PubMed    
    Abstract available

  219. AND ALTERNATIVE MEDICINE EC
    Retracted: Effect of MiR-375 Regulates YAP1 on the Invasion, Apoptosis, and Epithelial-Mesenchymal Transition of Cervical Cancer HeLa Cells.
    Evid Based Complement Alternat Med. 2023;2023:9787136.
    PubMed    
    Abstract available

  220. SCANNING
    Retracted: Evaluation of Pelvic Floor Dysfunction by Pelvic Floor Ultrasonography after Total Hysterectomy for Cervical Cancer.
    Scanning. 2023;2023:9853252.
    PubMed    
    Abstract available

  221. METHODS IN MEDICINE CAM
    Retracted: Expression of GMFB in High-Grade Cervical Intraepithelial Neoplasia and Its Role in Cervical Cancer.
    Comput Math Methods Med. 2023;2023:9834985.
    PubMed    
    Abstract available

  222. LIN CL, Ying TH, Yang SF, Lin CL, et al
    Magnolin targeting of the JNK/Sp1/MMP15 signaling axis suppresses cervical cancer microenvironment and metastasis via microbiota modulation.
    Cancer Lett. 2023 Dec 18:216584. doi: 10.1016/j.canlet.2023.216584.
    PubMed    
    Abstract available

  223. KUSHWAH AS, Masood S, Mishra R, Banerjee M, et al
    Genetic and epigenetic alterations in DNA repair genes and treatment outcome of Chemoradiotherapy in Cervical cancer.
    Crit Rev Oncol Hematol. 2023 Dec 18:104240.
    PubMed    
    Abstract available

  224. MUDRINICH SM, Nguyen MLT, Blemur DM, Wang X, et al
    An Alternative to Cytology in Triaging Cisgender Men and Transgender Women With HIV for High-Resolution Anoscopy.
    J Low Genit Tract Dis. 2024;28:101-106.
    PubMed    
    Abstract available

  225. PERKINS RB, Guido RS, Castle PE, Chelmow D, et al
    2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023.
    J Low Genit Tract Dis. 2024;28:3-6.
    PubMed    
    Abstract available

  226. AN L, Dong K, Chi S, Wei S, et al
    lncRNA UCA1 promotes tumor progression by targeting SMARCD3 in cervical cancer.
    Mol Carcinog. 2023 Dec 20. doi: 10.1002/mc.23659.
    PubMed    
    Abstract available

  227. HOLT HK, Flores R, James JE, Waters C, et al
    A qualitative study of primary care clinician's approach to ending cervical cancer screening in older women in the United States.
    Prev Med Rep. 2023;36:102500.
    PubMed    
    Abstract available

  228. BENJAMIN KA, Lamberti N, Cooke M
    Predictors of non-adherence to cervical cancer screening among immigrant women in Ontario, Canada.
    Prev Med Rep. 2023;36:102524.
    PubMed    
    Abstract available

  229. ZHANG F, Yu P, Xu L, Chen X, et al
    Differences of characteristics, influencing factors, and treatment effects on the survival in patients with first and second primary cervical cancer.
    Prev Med Rep. 2023;36:102504.
    PubMed    
    Abstract available

  230. ARROYO MUHR LS, Lagheden C, Hassan SS, Eklund C, et al
    The International Human Papillomavirus Reference Center: Standardization, collaboration, and quality assurance in HPV research and diagnostics.
    J Med Virol. 2023;95:e29332.
    PubMed    
    Abstract available

  231. YILMAZ A, Gulbahar A, Sen S
    Comparison of the efficacy of 5% versus 8% acetic acid concentrations for detecting premalignant and malignant lesions in colposcopy.
    Medicine (Baltimore). 2023;102:e36341.
    PubMed    
    Abstract available

  232. HUANG Y, Qin T, Yang M, Liu Z, et al
    Impact of ovary-sparing treatment planning on plan quality, treatment time and gamma passing rates in intensity-modulated radiotherapy for stage I/II cervical cancer.
    Medicine (Baltimore). 2023;102:e36373.
    PubMed    
    Abstract available

  233. SKELIN J, Luk HY, Butorac D, Boon SS, et al
    The effects of HPV oncoproteins on host communication networks: Therapeutic connotations.
    J Med Virol. 2023;95:e29315.
    PubMed    
    Abstract available

  234. ROCHA MARTINS P, Luciano Pereira Morais K, de Lima Galdino NA, Jacauna A, et al
    Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancer.
    Sci Rep. 2023;13:22634.
    PubMed    
    Abstract available

  235. LI Q, Zhu G, Zhang L, Zeng B, et al
    Mutational landscape of head and neck cancer and cervical cancer in Chinese and Western population.
    Head Neck. 2023 Dec 18. doi: 10.1002/hed.27603.
    PubMed    
    Abstract available

  236. YAN J, Wu T, Zhang J, Gao Y, et al
    Revolutionizing the female reproductive system research using microfluidic chip platform.
    J Nanobiotechnology. 2023;21:490.
    PubMed    
    Abstract available

  237. LI L, Tong Y, Wu J, Xu X, et al
    Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker.
    Cancer Cell Int. 2023;23:329.
    PubMed    
    Abstract available

  238. ROMERO D
    Neoadjuvant chemoimmunotherapy is effective in locally advanced cervical cancer.
    Nat Rev Clin Oncol. 2023 Dec 18. doi: 10.1038/s41571-023-00855.
    PubMed    


  239. YAO S, Xiong B, Tuo JY, Qin Y, et al
    [Survival analysis of malignant tumors in cancer registration areas of Hubei province in China, 2013 to 2015].
    Zhonghua Zhong Liu Za Zhi. 2023;45:1051-1056.
    PubMed    
    Abstract available

  240. CHEN Y, Chen Q, Xue H, Zheng J, et al
    Clinical Characteristics and Detection Sensitivity of Cervical Cancer Screening in Vaginal Intraepithelial Neoplasia.
    J Low Genit Tract Dis. 2023 Dec 18. doi: 10.1097/LGT.0000000000000793.
    PubMed    
    Abstract available

  241. ZHAO J, Li B, Shu C, Ma Y, et al
    [Retracted] Downregulation of miR?30a is associated with proliferation and invasion via targeting MEF2D in cervical cancer.
    Oncol Lett. 2023;27:35.
    PubMed    
    Abstract available

  242. TIE H, Shi L, Wang L, Hao X, et al
    Symptom clusters and characteristics of cervical cancer patients receiving concurrent chemoradiotherapy: A cross-sectional study.
    Heliyon. 2023;9:e22407.
    PubMed    
    Abstract available

  243. PIRANI N, Jafari M, Bagherzadeh R, Keikhosravi M, et al
    Cervical Cancer Prevention, Its Challenges and Solutions in Iran and Worldwide: A Systematic Review.
    Iran J Public Health. 2023;52:2313-2324.
    PubMed    
    Abstract available

  244. WANG Y, Zhao J, Liang H, Liu J, et al
    Efficacy and safety of sintilimab plus albumin-bound-paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trial.
    EClinicalMedicine. 2023;65:102274.
    PubMed    
    Abstract available

  245. LI S, Liu J, Zhang Z, Wang W, et al
    Added-value of 3D amide proton transfer MRI in assessing prognostic factors of cervical cancer: a comparative study with multiple model diffusion-weighted imaging.
    Quant Imaging Med Surg. 2023;13:8157-8172.
    PubMed    
    Abstract available

  246. SHARMA P, Khanna D, Pradhan S, Birur P, et al
    Community cancer screening at primary care level in Northern India: determinants and policy implications for cancer prevention.
    Fam Med Community Health. 2023;11.
    PubMed    
    Abstract available

  247. AMPOFO AG, Mackenzie LJ, Osei Asibey S, Oldmeadow C, et al
    Prevalence and Correlates of Cervical Cancer Prevention Knowledge Among High School Students in Ghana.
    Health Educ Behav. 2023 Dec 17:10901981231217978. doi: 10.1177/10901981231217978
    PubMed    
    Abstract available

  248. ANNEDE P, Robert C, Espenel S, Dumas I, et al
    Redefining the role of pulsed-dose-rate brachytherapy in cervical cancer treatment using a preplanned approach.
    Brachytherapy. 2023 Dec 16:S1538-4721(23)01677.
    PubMed    
    Abstract available

  249. ZHANG C, Liu L, Li W, Li M, et al
    Upregulation of FAM83F by c-Myc promotes cervical cancer growth and aerobic glycolysis via Wnt/beta-catenin signaling activation.
    Cell Death Dis. 2023;14:837.
    PubMed    
    Abstract available

  250. SOLEYMANI MAJD H, Yancheva S, Abdul B, Hellner K, et al
    Emergency hysterectomy following iatrogenic injury to the descending branch of the uterine artery during colposcopy.
    BMJ Case Rep. 2023;16:e255202.
    PubMed    
    Abstract available

  251. NEHA, Ranjan P, Das P
    Calcimycin mediates apoptosis in breast and cervical cancer cell lines by inducing intracellular calcium levels in a P2RX4-dependent manner.
    Biochim Biophys Acta Gen Subj. 2023;1868:130535.
    PubMed    
    Abstract available

  252. LIU S, Mei B, Ouyang Y, Li C, et al
    Prevalence and genotype distribution of human papillomavirus infection among women in Jingzhou, China: a population-based study of 51,720 women.
    Virol J. 2023;20:297.
    PubMed    
    Abstract available

  253. XU Q, Song Q, Wang Y, Lin L, et al
    Amide proton transfer weighted combined with diffusion kurtosis imaging for predicting lymph node metastasis in cervical cancer.
    Magn Reson Imaging. 2023;106:85-90.
    PubMed    
    Abstract available

  254. LEE S, Yoon H, Hong SH, Kwon SP, et al
    mRNA-HPV vaccine encoding E6 and E7 improves therapeutic potential for HPV-mediated cancers via subcutaneous immunization.
    J Med Virol. 2023;95:e29309.
    PubMed    
    Abstract available

  255. OKODO M, Okayama K, Teruya K, Shinohara R, et al
    Cytological features of human papillomavirus-infected immature squamous metaplastic cells from cervical intraepithelial neoplasia grade 2.
    J Med Virol. 2023;95:e29311.
    PubMed    
    Abstract available

  256. PARRA-LARA LG, Arango-Ibanez JP, Martinez-Arboleda JJ, Bravo JC, et al
    Survival of patients living with HIV and cancer in Cali, Colombia.
    Colomb Med (Cali). 2023;54:e2015558.
    PubMed    
    Abstract available

  257. WEI X, Zhang J, Mei Y, Dai Q, et al
    Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women's and Children's Central Hospital, 2015-2021, Chengdu, China.
    Sci Rep. 2023;13:22249.
    PubMed    
    Abstract available

  258. DONG J, Holthaus D, Peters C, Koster S, et al
    gammadelta T cell-mediated cytotoxicity against patient-derived healthy and cancer cervical organoids.
    Front Immunol. 2023;14:1281646.
    PubMed    
    Abstract available

  259. PASQUIER C, Raymond S, Duchanois D, Saune K, et al
    Human papillomavirus testing using HPV APTIMA(R) assay and an external cellularity control in self-collected samples.
    J Med Virol. 2023;95:e29283.
    PubMed    
    Abstract available

  260. HALL MT, Simms KT, Murray JM, Keane A, et al
    Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV.
    Nat Med. 2023;29:3059-3066.
    PubMed    
    Abstract available

  261. SIMMS KT, Keane A, Nguyen DTN, Caruana M, et al
    Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.
    Nat Med. 2023;29:3050-3058.
    PubMed    
    Abstract available

  262. SHAFIQUE M, Shoaib I, Aslam B, Khalid R, et al
    Detection of high-risk human papillomavirus infected cervical biopsies samples by immunohistochemical expression of the p16 tumor marker.
    Arch Microbiol. 2023;206:17.
    PubMed    
    Abstract available

  263. SHU T, Shi J, Zheng Y, Jiang Z, et al
    A Key-Points Based Anchor-Free Cervical Cell Detector.
    Annu Int Conf IEEE Eng Med Biol Soc. 2023;2023:1-5.
    PubMed    
    Abstract available

  264. YE Y, Li M, Yang W, Xu J, et al
    Characteristics of high-risk HPV infection in women with vaginal intraepithelial neoplasia in Beijing, China.
    J Med Virol. 2023;95:e29267.
    PubMed    
    Abstract available

  265. MANTINA NM, Nakayima Miiro F, Smith J, McClelland DJ, et al
    Perspectives of HPV vaccination among young adults: a qualitative systematic review and evidence synthesis protocol.
    BMJ Open. 2023;13:e076234.
    PubMed    
    Abstract available

  266. AHMED SR, Befano B, Lemay A, Egemen D, et al
    Reproducible and clinically translatable deep neural networks for cervical screening.
    Sci Rep. 2023;13:21772.
    PubMed    
    Abstract available

  267. RAMIREZ-LOPEZ LX, Carnalla-Cortes M, Barrientos-Gutierrez T, Coursaget P, et al
    Prophylactic cancer vaccines: development and challenges for HBV and HPV vaccines in Latin America.
    Salud Publica Mex. 2023;66.
    PubMed    
    Abstract available

  268. ADEBOLA A, Kehinde O, Glory O, Oluwafikunayomi A, et al
    MOTHERS WILLINGNESS TO VACCINATE THEIR IN-SCHOOL ADOLESCENTS AGAINST HPV INFECTION IN LAGOS STATE NIGERIA.
    West Afr J Med. 2023;40.
    PubMed    
    Abstract available

  269. RAJKHOWA P, Patil DS, Dsouza SM, Narayanan P, et al
    Evidence on factors influencing HPV vaccine implementation in South Asia: A scoping review.
    Glob Public Health. 2023;18:2288269.
    PubMed    
    Abstract available

  270. YANG X, He L, Xiao X, Yan L, et al
    Effectiveness of TruScreen for detecting CIN2+ in women with ThinPrep cytologic test results indicating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
    Future Oncol. 2023;19:2493-2504.
    PubMed    
    Abstract available

  271. YU J, Sun X, Yu Y, Cui X, et al
    The cadherin protein CDH19 mediates cervical carcinoma progression by regulating AKT/NF-kappaB signaling.
    Acta Biochim Pol. 2023;70:955-961.
    PubMed    
    Abstract available

  272. BARNABAS RV, Brown ER, Onono MA, Bukusi EA, et al
    Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results.
    Nat Med. 2023 Dec 4. doi: 10.1038/s41591-023-02658.
    PubMed    
    Abstract available

  273. KIM MJ, Lee GJ, Lee EJ, Lee S, et al
    Lugol's Solution Reduces Positive Margins and Residual Disease After the Large Loop Excision of Transformation Zone.
    J Low Genit Tract Dis. 2024;28:12-17.
    PubMed    
    Abstract available

  274. MENESES-LEON J, Hernandez-Lopez R, Hernandez-Salazar S, Torres-Ibarra L, et al
    Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections in Tlaxcala, Mexico.
    Epidemiol Infect. 2023;151:e198.
    PubMed    
    Abstract available

  275. AGGARWAL S, Agarwal P, Singh AK
    Human papilloma virus vaccines: A comprehensive narrative review.
    Cancer Treat Res Commun. 2023;37:100780.
    PubMed    
    Abstract available

  276. FAN J, Lu F, Qin T, Peng W, et al
    Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance.
    Nat Genet. 2023;55:2175-2188.
    PubMed    
    Abstract available

  277. BI Y, Hu J, Zeng L, Chen G, et al
    Characteristics of HPV integration in cervical adenocarcinoma and squamous carcinoma.
    J Cancer Res Clin Oncol. 2023;149:17973-17986.
    PubMed    
    Abstract available

  278. SGAYER I, Shmueli M, Lowenstein L, Frank Wolf M, et al
    Colposcopy-A Valuable Diagnostic Tool for Pregnant Women With Unexplained Vaginal Bleeding.
    J Low Genit Tract Dis. 2024;28:32-36.
    PubMed    
    Abstract available

  279. LYCKE KD, Kalpathy-Cramer J, Jeronimo J, de Sanjose S, et al
    Agreement on Lesion Presence and Location at Colposcopy.
    J Low Genit Tract Dis. 2024;28:37-42.
    PubMed    
    Abstract available

  280. XU J, He J, Zhou YL, Weng Z, et al
    Von Willebrand factor promotes radiation-induced intestinal injury (RIII) development and its cleavage enzyme rhADAMTS13 protects against RIII by reducing inflammation and oxidative stress.
    Free Radic Biol Med. 2024;210:1-12.
    PubMed    
    Abstract available

  281. ZHANG Z, Li Y, Wu Y, Bi R, et al
    Identifying tumor markers-stratified subtypes (CA-125/CA19-9/carcinoembryonic antigen) in cervical adenocarcinoma.
    Int J Biol Markers. 2023;38.
    PubMed    
    Abstract available

  282. VIVEROS-CARRENO D, Mora-Soto N, Rodriguez J, Rauh-Hain JA, et al
    Recurrence After Biopsy-Confirmed Cervical High-Grade Intraepithelial Lesion Followed by Negative Conization: A Systematic Review and Meta-analysis.
    J Low Genit Tract Dis. 2024;28:26-31.
    PubMed    
    Abstract available

  283. SWIECKI-SIKORA AL, Lauder A, Harris A, Tagai EK, et al
    Attitudes About the Human Papillomavirus Vaccine Among Patients With and Without Cervical Dysplasia.
    J Low Genit Tract Dis. 2024;28:18-25.
    PubMed    
    Abstract available

  284. NEIL AJ, Li YY, Hakam A, Nucci MR, et al
    Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas.
    Histopathology. 2024;84:369-380.
    PubMed    
    Abstract available

  285. PIEDIMONTE S, Tsang K, Jembere N, Murphy J, et al
    Defining the Longitudinal Risk of CIN 3+ for
    J Low Genit Tract Dis. 2024;28:7-11.
    PubMed    
    Abstract available

  286. BABAN FS, Henry MR, Long ME, VandeHaar MA, et al
    Women 50 Years and Older With Negative Pap Test and Positive Human Papillomavirus Test for Genotypes Other Than 16 and 18-Follow-up Outcomes.
    J Low Genit Tract Dis. 2024;28:43-47.
    PubMed    
    Abstract available

  287. SONG Y, Zhang M, Zhang C, Du S, et al
    HPV E6/E7 mRNA combined with thin-prep cytology test for the diagnosis of residual/recurrence after loop electrosurgical excision procedure in patients with cervical intraepithelial neoplasia.
    Diagn Microbiol Infect Dis. 2024;108:116119.
    PubMed    
    Abstract available

  288. KUMARI N, Antil H, Kumari S, Raghavan SC, et al
    Deficiency of ligase IV leads to reduced NHEJ, accumulation of DNA damage, and can sensitize cells to cancer therapeutics.
    Genomics. 2023;115:110731.
    PubMed    
    Abstract available

  289. SOUID M, Bday J, Souissi S, Ghedira R, et al
    Arginase is upregulated in healthy women infected by oncogenic HPV types.
    Biomarkers. 2023;28:628-636.
    PubMed    
    Abstract available

  290. SHU X, Su J, Zhao Y, Liu C, et al
    Regulation of HeLa cell proliferation and apoptosis by bovine lactoferrin.
    Cell Biochem Funct. 2023;41:1395-1402.
    PubMed    
    Abstract available

  291. TONINI F, Forret A, Lanta S, Gagneur O, et al
    How to make a LLETZ simulator: LLETZ Simulator.
    J Gynecol Obstet Hum Reprod. 2023;52:102676.
    PubMed    
    Abstract available

  292. YING J, Mao L, Tang Y, Fassatoui M, et al
    Development and validation of real-time recombinase polymerase amplification-based assays for detecting HPV16 and HPV18 DNA.
    Microbiol Spectr. 2023;11:e0120723.
    PubMed    
    Abstract available

  293. YUAN LJ, He K, Zhu CX, Cao TF, et al
    Rational of topical photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) for treatment of endocervical canal low-grade squamous intraepithelial lesion with high-risk human papillomavirus infection.
    Lasers Surg Med. 2023;55:880-885.
    PubMed    
    Abstract available

  294. RAWL SM, Baltic R, Monahan PO, Stump TE, et al
    Receipt, uptake, and satisfaction with tailored DVD and patient navigation interventions to promote cancer screening among rural women.
    Transl Behav Med. 2023;13:879-890.
    PubMed    
    Abstract available

  295. ZHANG Z, Wang J, Yuan S
    Cervical perineural cyst: A case report.
    Asian J Surg. 2023;46:5809-5810.
    PubMed    


  296. ZHENG LL, Zheng LY, Chen C, Wang YT, et al
    High-risk human papillomavirus distribution in different cytological classification women.
    Microbes Infect. 2023;25:105214.
    PubMed    
    Abstract available

  297. MOAZZAM Z, Woldesenbet S, Endo Y, Alaimo L, et al
    Association of Historical Redlining and Present-Day Social Vulnerability with Cancer Screening.
    J Am Coll Surg. 2023;237:454-464.
    PubMed    
    Abstract available

  298. IKIROMA A, Santin O, Camanda J, Chocolate F, et al
    Evaluation of human papillomavirus (HPV) knowledge among healthcare professionals: A study of conference attendees in Angola.
    Glob Public Health. 2023;18:2099931.
    PubMed    
    Abstract available

  299. CANNISTRA S, Carozzi F, Di Stefano C, Matucci M, et al
    Accuracy and Reproducibility of Cytology Triage in a HPV-Based Primary Screening Setting: A Revision of 384 Pap Tests.
    Acta Cytol. 2023;67:618-628.
    PubMed    
    Abstract available

  300. PULKKINEN J, Huhtala H, Kholova I
    False-Positive Atypical Endocervical Cells in Conventional Pap Smears: Cyto-Histological Correlation and Analysis.
    Acta Cytol. 2023;67:604-617.
    PubMed    
    Abstract available

  301. BASCIO LS, Chiappa V, Paolini B, Chiarello G, et al
    Urothelial bladder carcinoma recurrence in the uterine cervix: Cytological findings on a cervical cytology test.
    Cytopathology. 2023;34:645-648.
    PubMed    


  302. NG JKM, Li JJX
    Keratinization in atypical glandular cell clusters as a cytological clue to endometrioid carcinoma on cervical cytology.
    Cytopathology. 2024;35:131-135.
    PubMed    
    Abstract available

  303. POGERE A, Costa AF, Pasinato APBF, Machado MJ, et al
    Role of DNA ploidy in diagnosis and prognosis of high-grade cervical intraepithelial neoplasia: A prospective cohort study.
    Cytopathology. 2024;35:122-130.
    PubMed    
    Abstract available

  304. TOROUS VF
    Challenging lesions in cervical cytology: The elusive HSIL.
    Cytopathology. 2024;35:48-59.
    PubMed    
    Abstract available

  305. CHEN L, Zhu K, Chen H, Liu Q, et al
    Correlation of immediate prevalence of cervical squamous cell precancers and cancers with HPV genotype and age in women with LSIL cytology: A retrospective analysis of 1617 cases.
    Diagn Cytopathol. 2024;52:10-15.
    PubMed    
    Abstract available

  306. HSIEH K, Bloom JR, Dickstein DR, Hsieh C, et al
    Dose and fractionation regimen for brachytherapy boost in cervical cancer in the US.
    Gynecol Oncol. 2023;180:55-62.
    PubMed    
    Abstract available

  307. RAI R, Lightfoot S, Benbrook DM
    Manipulation of metabolic responses enhances SHetA2 efficacy without toxicity in cervical cancer cell lines and xenografts.
    Gynecol Oncol. 2023;180:44-54.
    PubMed    
    Abstract available

  308. SAMMOURI J, Venkatesan AM, Lin LL, Jhingran A, et al
    Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement.
    Gynecol Oncol. 2023;180:24-34.
    PubMed    
    Abstract available

  309. VAHTERISTO M, Leinonen MK, Sarkeala T, Anttila A, et al
    Similar effectiveness with primary HPV and cytology screening - Long-term follow-up of randomized cervical cancer screening trial.
    Gynecol Oncol. 2023;180:146-151.
    PubMed    
    Abstract available

  310. URBUTE A, Frederiksen K, Thomsen LT, Kesmodel US, et al
    Overweight and obesity as risk factors for cervical cancer and detection of precancers among screened women: A nationwide, population-based cohort study.
    Gynecol Oncol. 2023;181:20-27.
    PubMed    
    Abstract available

  311. LONG E, Macdonald MC, Parker VL, Lyon R, et al
    Factors associated with failed 'test of cure' in the NHS Cervical Screening Programme: A retrospective cohort study.
    Gynecol Oncol. 2023;179:158-163.
    PubMed    
    Abstract available

  312. COCUZZA CE, Dhillon SK, Martinelli M, Giubbi C, et al
    Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.
    Int J Cancer. 2023 Oct 19. doi: 10.1002/ijc.34754.
    PubMed    
    Abstract available

  313. DESRAVINES N, Hsu CH, Mohnot S, Sahasrabuddhe V, et al
    Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
    Int J Gynaecol Obstet. 2023;163:862-867.
    PubMed    
    Abstract available

  314. VAN DE SANDE AJM, Kengsakul M, Koeneman MM, Jozwiak M, et al
    The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2024;164:66-74.
    PubMed    
    Abstract available

  315. BORGHI C, Biagioli E, Mauro J, Roberto A, et al
    Neoadjuvant chemotherapy prior to radical hysterectomy in locally advanced cervical cancer: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2023 Nov 27:ijgc-2023-004863.
    PubMed    
    Abstract available

  316. RIBEIRO R, Baiocchi G, Moretti-Marques R, Linhares JC, et al
    Uterine transposition for fertility and ovarian function preservation after radiotherapy.
    Int J Gynecol Cancer. 2023;33:1837-1842.
    PubMed    
    Abstract available

  317. PARPINEL G, Laas-Faron E, Balaya V, Guani B, et al
    Survival after sentinel lymph node biopsy for early cervical cancers: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2023;33:1853-1860.
    PubMed    
    Abstract available

  318. PLAIKNER A, Siegler K, Kohler C
    Surgical steps of laparoscopic-assisted simple vaginal trachelectomy.
    Int J Gynecol Cancer. 2023;33:1972-1973.
    PubMed    



  319. Association of Radical Hysterectomy Surgical Volume and Survival for Early-Stage Cervical Cancer: Correction.
    Obstet Gynecol. 2024;143:e21.
    PubMed    


  320. ZEWDIE A, Shitu S, Kebede N, Gashaw A, et al
    Determinants of late-stage cervical cancer presentation in Ethiopia: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:1228.
    PubMed    
    Abstract available

  321. VIGNESHWARAN E, Goruntla N, Bommireddy BR, Mantargi MJS, et al
    Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
    BMC Cancer. 2023;23:1216.
    PubMed    
    Abstract available

  322. KONG L, Xiao X, Xu T, Wan R, et al
    Immediate histologic correlation in patients with different HPV genotypes and ages: a single center analysis in China.
    BMC Cancer. 2023;23:1211.
    PubMed    
    Abstract available

  323. TACHIWENYIKA E, Dhodho M, Muchedzi A, Sibanda TP, et al
    Prevalence of Cervical Cancer and Clinical Management of Women Screened positive using visual inspection with acetic acid and Cervicography in selected public sector health facilities of Manicaland and Midlands provinces of Zimbabwe, 2021.
    PLoS One. 2023;18:e0294115.
    PubMed    
    Abstract available

  324. MAHUMUD RA, Alam K, Dunn J, Gow J, et al
    Correction: The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.
    PLoS One. 2023;18:e0295688.
    PubMed    
    Abstract available

  325. QULU W, Mtshali A, Osman F, Ndlela N, et al
    High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV.
    PLoS One. 2023;18:e0294698.
    PubMed    
    Abstract available

  326. ALMASOUDI HH, Nahari MH, Alhazmi AYM, Almasabi SHA, et al
    Delineating Pixantrone Maleate's adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation.
    PLoS One. 2023;18:e0295714.
    PubMed    
    Abstract available

  327. RAZZAK MA, Islam MN, Aadeeb MS, Tasnim T, et al
    Digital health interventions for cervical cancer care: A systematic review and future research opportunities.
    PLoS One. 2023;18:e0296015.
    PubMed    
    Abstract available

  328. AL-OSEELY S, Abdul Manaf R, Ismail S
    Factors affecting cervical cancer screening among Yemeni immigrant women in Klang Valley, Malaysia: A cross sectional study.
    PLoS One. 2023;18:e0290152.
    PubMed    
    Abstract available

  329. GEBREMESKEL TG, Gebretatios MZ
    Determinants of cervical cancer screening utilization among HIV-positive women, in public general hospitals of Central Zone, Tigray, Ethiopia, 2020: Case-control study.
    PLoS One. 2023;18:e0289042.
    PubMed    
    Abstract available

  330. NOVAIS IR, Coelho CO, Machado HC, Surita F, et al
    Cervical cancer screening in Brazilian Amazon Indigenous women: Towards the intensification of public policies for prevention.
    PLoS One. 2023;18:e0294956.
    PubMed    
    Abstract available

  331. TOSADO-RODRIGUEZ E, Mendez LB, Espino AM, Dorta-Estremera S, et al
    Inflammatory cytokines and a diverse cervicovaginal microbiota associate with cervical dysplasia in a cohort of Hispanics living in Puerto Rico.
    PLoS One. 2023;18:e0284673.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;